ISENTRESS

Product NDC
70518-1621
11-digit product format
705181621
Labeler code
70518
Product ID
70518-1621_d9b8c0ba-9b03-6518-e053-2995a90ada6d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
RALTEGRAVIR
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
NDA022145
Marketing category
NDA
Marketing start
2018-10-31
Marketing end
0000-00-00
Substance
RALTEGRAVIR POTASSIUM
Active strength
400 mg/1
Pharmacologic classes
HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-1621ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [REMEDYREPACK INC.]8Legacy NDC20250226_cf9085f0-7353-40e1-bc40-0295ace92aab.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
70518-1621-07051816210030 TABLET, FILM COATED in 1 BLISTER PACK (70518-1621-0) 2018-10-310000-00-00NoNoCurrent
70518-1621-1705181621016 TABLET, FILM COATED in 1 BLISTER PACK (70518-1621-1) 2019-01-170000-00-00NoNoCurrent
70518-1621-2705181621028 TABLET, FILM COATED in 1 BLISTER PACK (70518-1621-2) 2019-01-170000-00-00NoNoCurrent